Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bast

Showing results (141-150 of 299) with videos related to

Pageof 30
Sort By:
Obstetrics and Gynecology|February 1, 1987
CA 125 for the monitoring of ovarian carcinoma during primary therapyP T Lavin, R C Knapp, G Malkasian, et al.
In Vivo (Athens, Greece)|July 1, 1995
Toward salivary-urinary chronosensitivity testing: chronomes of OVX1, M-CSF and CA130F Xu, Y Yu, R C Bast, et al.
Gynecologic Oncology|July 1, 1990
Antigenic heterogeneity in human ovarian cancerW R Welch, J M Niloff, D Anderson, et al.
American Journal of Obstetrics and Gynecology|April 1, 1996
Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancerG Olt, J Soper, S Ramakrishnan, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1983
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125S E Kabawat, R C Bast, A K Bhan, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinomaJ T Soper, A Berchuck, G J Olt, et al.
Obstetrics and Gynecology|July 11, 1992
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancerN Einhorn, K Sjövall, R C Knapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 1992
Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigenL Daly, J Ferguson, G P Cram, et al.
Gynecologic Oncology|October 29, 1998
A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancerD M Gershenson, T W Burke, M Morris, et al.
Cancer Research|February 1, 1985
Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complementR C Bast, P De Fabritiis, J Lipton, et al.
Pageof 30

Showing results (141-150 of 299) with videos related to

Sort By:
Pageof 30
Obstetrics and Gynecology|February 1, 1987
CA 125 for the monitoring of ovarian carcinoma during primary therapyP T Lavin, R C Knapp, G Malkasian, et al.
In Vivo (Athens, Greece)|July 1, 1995
Toward salivary-urinary chronosensitivity testing: chronomes of OVX1, M-CSF and CA130F Xu, Y Yu, R C Bast, et al.
Gynecologic Oncology|July 1, 1990
Antigenic heterogeneity in human ovarian cancerW R Welch, J M Niloff, D Anderson, et al.
American Journal of Obstetrics and Gynecology|April 1, 1996
Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancerG Olt, J Soper, S Ramakrishnan, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1983
Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125S E Kabawat, R C Bast, A K Bhan, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinomaJ T Soper, A Berchuck, G J Olt, et al.
Obstetrics and Gynecology|July 11, 1992
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancerN Einhorn, K Sjövall, R C Knapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 1992
Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigenL Daly, J Ferguson, G P Cram, et al.
Gynecologic Oncology|October 29, 1998
A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancerD M Gershenson, T W Burke, M Morris, et al.
Cancer Research|February 1, 1985
Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complementR C Bast, P De Fabritiis, J Lipton, et al.
Pageof 30